SCHEMBL7433792

SCHEMBL7433792

Nc1c(Cl)cc(C(=O)NCC2CN3CCN2CC3)c2c1OCCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 3/20 0.48
HTR3A P46098 3/20 0.43
HTR2C P28335 2/20 0.43
HTR3E A5X5Y0 2/20 0.43
HTR3B O95264 2/20 0.43
HTR3D Q70Z44 2/20 0.43
HTR3C Q8WXA8 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
LMNA P02545 1/20 0.43
ADRA2A P08913 1/20 0.43
THRB P10828 1/20 0.43
ADRA2C P18825 1/20 0.43
HTR1D P28221 1/20 0.43
HTR2A P28223 1/20 0.43
ADRA1A P35348 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8870522 0.99 HTR4 (0.47) HTR4HTR3AHTR2CHTR3EHTR3B
SCHEMBL7436666 0.96 HTR4 (0.44) HTR4HTR3AHTR2CHTR3EHTR3B
SCHEMBL7436618 0.87 HTR4 (0.35) HTR4
SCHEMBL8048001 0.82 HTR4 (0.64) HTR4HTR3AHTR2CHTR3EHTR3B
Hydrochloric Acid SCHEMBL27351488 0.77 HTR4 (0.66) HTR4HTR3AHTR2CHTR3EHTR3B
SCHEMBL7434391 0.75 DRD2 (0.40) HTR3A
SCHEMBL7751844 0.75 HTR4 (0.50) HTR4HTR3AHTR2CHTR3EHTR3B
SCHEMBL506271 0.75 HTR4 (0.57) HTR4HTR3A
Hydrochloric Acid SCHEMBL8871742 0.74 DRD2 (0.40) HTR3A
SCHEMBL7436348 0.74 HTR4 (0.63) HTR4HTR3AHTR3EHTR3BHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663173-A CENTRAL NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS, PYCHOSES, ANTIDEPRESSANTS AND EATING DISORDERS SYNTHELABO (FR) 1997-09-02 US claimed
EP-0748807-A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use SYNTHELABO (FR) 1996-12-18 EP claimed
US-5663173-A CENTRAL NERVOUS SYSTEM DISORDERS, COGNITION ACTIVATORS, PYCHOSES, ANTIDEPRESSANTS AND EATING DISORDERS SYNTHELABO (FR) 1997-09-02 US disclosed
EP-0748807-A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use SYNTHELABO (FR) 1996-12-18 EP disclosed